Predicting the effect of different folate doses on [(68)Ga]Ga-PSMA-11 organ and tumor uptake using physiologically based pharmacokinetic modeling

por Siebinga, Hinke, Hendrikx, Jeroen J. M. A., Huitema, Alwin D. R., de Wit-van der Veen, Berlinda J.
Publicado 2023

Current use and future potential of (physiologically based) pharmacokinetic modelling of radiopharmaceuticals: a review

por Siebinga, Hinke, de Wit-van der Veen, Berlinda J., Stokkel, Marcel D.M., Huitema, Alwin D.R., Hendrikx, Jeroen J.M.A.
Publicado 2022

Somatostatin receptor saturation after administration of high peptide amounts of [(177)Lu]Lu-HA-DOTATATE: when enough is enough

por Siebinga, Hinke, Veerman, Chayenne H. A. M., de Wit-van der Veen, Linda, Stokkel, Marcel P. M., Hendrikx, Jeroen J. M. A., Aalbersberg, Else A.
Publicado 2022

A physiologically based pharmacokinetic model for [(68)Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients

por Siebinga, Hinke, de Wit-van der Veen, Berlinda J., Beijnen, Jos H., Dorlo, Thomas P. C., Huitema, Alwin D. R., Hendrikx, Jeroen J. M. A.
Publicado 2023

Predicting [(177)Lu]Lu-HA-DOTATATE kidney and tumor accumulation based on [(68)Ga]Ga-HA-DOTATATE diagnostic imaging using semi-physiological population pharmacokinetic modeling

por Siebinga, Hinke, de Wit-van der Veen, Berlinda J., Beijnen, Jos H., Stokkel, Marcel P. M., Dorlo, Thomas P. C., Huitema, Alwin D. R., Hendrikx, Jeroen J. M. A.
Publicado 2023

Population pharmacokinetic dosimetry model using imaging data to assess variability in pharmacokinetics of (177)Lu‐PSMA‐617 in prostate cancer patients

por Siebinga, Hinke, Privé, Bastiaan M., Peters, Steffie M. B., Nagarajah, James, Dorlo, Thomas P. C., Huitema, Alwin D. R., de Wit‐van der Veen, Berlinda J., Hendrikx, Jeroen J. M. A.
Publicado 2023